| 1 |
Hoste EA,Bagshaw SM,Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study [J]. Intensive Care Med, 2015, 41(8): 1411-1423.
|
| 2 |
Kellum JA,Bellomo R,Ronco C, et al. Kidney attack [J]. JAMA, 2012, 307(21): 2265-2266.
|
| 3 |
KDIGO: clinical practice guideline for acute kidney injury [J]. Kidney Int Suppl, 2012, 2: 1-138.
|
| 4 |
Bellomo R,Ronco C,Mehta RL, et al. Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference [J]. Ann Intensive Care, 2017, 7(1): 49.
|
| 5 |
Bagshaw SM,Gibney RT. Conventional markers of kidney function [J]. Crit Care Med, 2008, 36(4): 152.
|
| 6 |
Mehta RL,Kellum JA,Shah SV, et al. Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury [J]. Crit Care, 2007, 11: 31.
|
| 7 |
Murray PT,Mehta RL,Shaw A, et al. Potential use of biomarkers in acute kidney injury: Report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference [J]. Kidney Int, 2014, 85(3): 513-521.
|
| 8 |
Siew ED,Ware LB,Ikizler TA. Biological markers of acute kidney injury [J]. J Am Soc Nephrol, 2011, 22(5): 810-820.
|
| 9 |
Malhotra R,Kashani KB,Macedo E, et al. A risk prediction score for acute kidney injury in the intensive care unit [J]. Nephrol Dial Transplant, 2017, 32(5): 814-822.
|
| 10 |
Vanmassenhove J,Vanholder R,Nagler E, et al. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature [J]. Nephrol Dial Transplant, 2013, 28(2): 254.
|
| 11 |
Degeorges A,Wang F,FH Jr, et al. Distribution of IGFBP-rP1 in normal human tissues [J]. J Histochem Cytochem, 2000, 48(6): 747-754.
|
| 12 |
Emlet D,Pastor-Soler N,Marciszyn A, et al. Insulin-like growth factor binding protein 7 and tissue inhibitor of metalloproteinases-2: differential expression and secretion in human kidney tubule cells [J]. Am J Physiol Renal Physiol, 2017, 312(2): 284-296.
|
| 13 |
Zarbock A,Schmidt C,van Aken H, et al. Effect of remote ischemic preconditioning on kidney injury among high-risk patients un- dergoing cardiac surgery: a randomized clinical trial [J]. JAMA, 2015, 313(21): 2133-2141.
|
| 14 |
Devarajan P. Update on mechanisms of ischemic acute kidney injury [J]. J Am Soc Nephrol, 2006, 17(6): 1503-1520.
|
| 15 |
Waikar SS,Betensky RA,Emerson SC, et al. Imperfect gold standards for kidney injury biomarker evaluation [J]. J Am Soc Nephrol, 2012, 23(1): 13-21.
|
| 16 |
Rodier F,Campisi J,Bhaumik D. Two faces of p53: aging and tumor suppression [J]. Nucleic Acids Res, 2007, 35(22): 7475-7484.
|
| 17 |
Boonstra J,Post J. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells [J]. Gene, 2004, 337(35): 1-13.
|
| 18 |
Kashani K,Al-Khafaji A,Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury [J]. Crit Care, 2013, 17: 25.
|
| 19 |
Hoste EA,McCullough PA,Kashani K, et al. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers [J]. Nephrol Dial Transplant, 2014, 29(11): 2054-2061.
|
| 20 |
Liu C,Lu XC,Mao Z, et al. The diagnostic accuracy of urinary [TIMP-2] • [IGFBP7] for acute kidney injury in adults A PRISMA-compliant meta-analysis [J]. Medicine, 2017, 96(27): e7484.
|
| 21 |
Meersch M,Schmidt C,van Aken H, et al. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery [J]. PLoS One, 2014, 9(3): e93460.
|
| 22 |
Gocze I,Koch M,Renner P, et al. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery [J]. PLoS One, 2015, 10(3): e0120863.
|
| 23 |
Aregger F,Uehlinger DE,Witowski J, et al. Identification of IGFBP-7 by urinary proteomics as a novel prognostic marker in early acute kidney injury [J]. Kidney Int, 2014, 85(4): 909-919.
|
| 24 |
Dong L,Ma Q,Bennett M, et al. Urinary biomarkers of cell cycle arrest are delayed predictors of acute kidney injury after pediatric cardiopulmonary bypass [J]. Pediatr Nephrol, 2017, 32 (1): 1-10.
|
| 25 |
Koyner JL,Shaw AD,Chawla LS, et al. Tissue inhibitor metalloproteinase-2 (TIMP-2)•IGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI [J]. J Am Soc Nephrol, 2015, 26(7): 1747-1754.
|
| 26 |
Bell M,Larsson A,Venge P, et al. Assessment of cell-cycle arrest biomarkers to predict early and delayed acute kidney injury [J]. Dis Markers, 2015, 2015(5): 158658.
|
| 27 |
Beitland,Waldumgrevbo BE,Nakstad ER, et al. Urine biomarkers give early prediction of acute kidney injury and outcome after out- of-hospital cardiac arrest [J]. Critical Care, 2016, 20(1): 314.
|